| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C16H16ClNO2 |
| Molar mass | 289.76 g·mol−1 |
| 3D model (JSmol) | |
| |
SKF-81,297 is asyntheticdrug of thebenzazepinechemical class that acts as aselectivedopamine D1/D5 receptorfull agonist, and produces a characteristicstimulant-like pattern ofanorexia,hyperactivity andself-administration in animals.[1] This profile is shared with several related drugs such as6-Br-APB andSKF-82,958,[2] but not with certain other D1 full agonists such asA-77,636, reflectingfunctional selectivity of D1 activation.[3][4][5] Newer findings reveal that SKF-81,297 additionally acts as a partial agonist atD1-D2 receptor heteromers.[6]
One of the patented uses for SKF-81,297 is as an augmentation agent when combined with an appropriate choice of an antidepressant.[7]
Thisdrug article relating to thegastrointestinal system is astub. You can help Wikipedia byexpanding it. |